L
LinkinVax
Biotech & Life Sciences · Paris, France · Founded 2020
Operates as a clinical-stage biotechnology company MoreLess
LinKinVax is a French biotechnology startup specializing in the rapid development of vaccines by integrating basic scientific research with industrial processes. The company operates in the biotechnology sector, focusing on creating highly versatile and efficient vaccines. LinKinVax serves pharmaceutical companies, healthcare providers, and research institutions looking for advanced vaccine solutions. The business model revolves around research and development (R&D) partnerships, clinical trials, and licensing agreements. Revenue is generated through collaboration fees, milestone payments, and royalties from licensed vaccines. The company is currently involved in a Phase I/IIa clinical study on HPV, showcasing its commitment to addressing critical healthcare needs.
Keywords: biotechnology, vaccine development, clinical trials, HPV, R&D partnerships, licensing, healthcare, pharmaceutical, industrial processes, innovation.
Talent graph
LinkinVax's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where LinkinVax has talent and traffic
Market sentiment
What the market is saying about LinkinVax
An AI-synthesized read of the highest-engagement posts about LinkinVax on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LinkinVax on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.